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Abstract
The Type VI secretion system (T6SS) is a protein translocation nanomachine wide-
spread among Gram-negative bacteria and used as a means to deliver effectors
directly into target bacterial or eukaryotic cells. These effectors have a wide variety
of functions within target cells that ultimately help the secreting cell gain a competi-
tive fitness advantage. Here, we discuss the different ways in which these effectors
can be delivered by the T6SS and the diverse mechanisms by which they exert their
noxious action upon recipient cells. We also highlight the existence of roles for T6SS
effectors beyond simply the killing of neighbouring cells.
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1 | INTRODUCTION
Bacteria have evolved specialised protein secretion systems in order
to deliver a wide variety of proteins into the extracellular space or
even directly into other cells. Secretion systems allow bacteria to
interact with their environment, a host organism or other bacteria.
The Type VI secretion system (T6SS) is widespread in Gram-negative
bacteria and can translocate toxic proteins, known as “effectors,”
across the membrane of a neighbouring target cell. The primary role
of the T6SS appears to be to act against competitor bacteria, with the
potential to shape diverse polymicrobial communities, however, this
versatile machinery can also be used against eukaryotic cells and to
release metal-scavenging proteins extracellularly (Coulthurst, 2019).
The T6SS is a large, contractile nanomachine, which expels a
puncturing structure, made of a tube of Hcp (TssD) with a distal spike
of VgrG (TssI) and PAAR proteins, decorated with effector proteins,
out of the secreting cell (Figure 1a). As reviewed recently (Nguyen
et al., 2018; Wang, Brodmann, & Basler, 2019), the T6SS operates via
dynamic cycles of assembly, contraction and disassembly. A mem-
brane complex (TssJLM) acts as a docking site for a cytoplasmic
baseplate-like structure (TssEFGK), built around a central (VgrG)3-
PAAR spike. The Hcp tube then assembles onto VgrG, surrounded by
a contractile sheath made of TssBC, which polymerises in a high-
energy extended conformation. Assembly is coordinated by TssA,
which typically forms a cap at the distal end of the sheath and tube,
although in some systems remains associated with the baseplate
(Schneider et al., 2019). The sheath then contracts in a rapid firing
step, propelling the Hcp–VgrG–PAAR puncturing structure out of the
secreting cell and into the target cells, delivering the effector payload.
Finally, the contracted sheath is disassembled by TssH (ClpV). T6SSs
are encoded by large variable gene clusters, which contain genes
encoding the essential core components (TssA-TssM and PAAR), and
often also conserved accessory proteins involved in post-translational
regulation or assembly of the machinery. T6SS-wielding bacteria typi-
cally also possess a number of species- or strain-specific T6SS genes,
within and outside the main T6SS cluster, encoding regulators, effec-
tors, immunity proteins and other effector-associated proteins
(Coulthurst, 2019).
The T6SS can use its contraction-based mechanism to deliver a
wide variety of effectors into target cells. Here, we examine recent
advances in understanding T6SS-delivered effector proteins, consider-
ing their mode of delivery, action against different kingdoms and how
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the effector repertoire delivered by a particular T6SS may determine
its role.
2 | MODES OF EFFECTOR DELIVERY BY
THE T6SS
In order to be secreted, effectors delivered by the T6SS associate with
the expelled puncturing structure in two distinct ways: “Cargo” effec-
tors interact non-covalently with one of the components of the
puncturing structure (Hcp, VgrG or PAAR), whereas “specialised”
effectors represent additional homologues of one of these compo-
nents that carry an additional effector domain covalently fused to the
core domain, almost always at the C-terminus (Figure 1b). Hcp-
dependent cargo effectors sit within the lumen of the Hcp tube,
which is formed of stacked hexamers of Hcp. This tube has an internal
diameter of 40 Å, and consequently Hcp-dependent effectors typi-
cally have a molecular weight under 20 kDa. Silverman et al. (2013)
showed that Hcp1 from Pseudomonas aeruginosa could stabilise and
protect its substrates, Tse1-3, from proteolysis, revealing that Hcp is
F IGURE 1 Mechanism of effector delivery by the Type VI secretion system. (a) Schematic representation of assembly, firing and disassembly
of the T6SS. The T6SS assembles in the “extended” conformation (left). The cytoplasmic baseplate (TssEFGK), containing the VgrG–PAAR spike,
docks on the membrane complex (TssJLM) and then acts as a platform for the assembly of the Hcp tube surrounded by the extended TssBC
sheath. In a rapid “firing” step (middle), contraction of the TssBC sheath propels the Hcp–VgrG–PAAR structure out of the secreting cell and into
an appropriately positioned target cell, where effectors are somehow released. Finally, disassembly (right), involves depolymerisation of the
contracted sheath by TssH, allowing the system to partially or fully disassemble, often move to a new location, and begin another round of
assembly and firing. CP, cytoplasm; IM, inner membrane; OM, outer membrane; PG, peptidoglycan cell wall. (b) Schematic representation of the
different modes of delivery of T6SS effectors. Effectors delivered by the T6SS can be classified as either “cargo” or “specialised” effectors, based
on their interaction with the components of the puncturing structure (Hcp, VgrG or PAAR). Cargo effectors (left) non-covalently interact with the
lumen of Hcp hexamers or the exterior of the VgrG–PAAR spike, whereas specialised effectors (right) represent covalent fusions between core
Hcp, VgrG or PAAR proteins with an additional effector domain. In some cases, specific adaptor proteins are required for stabilisation and/or
loading of particular effectors during T6SS assembly. Tap-1 adaptors (DUF4123, also known as Tec) assist loading of cargo effectors onto VgrG
proteins, while Eag adaptors (DUF1795) act as chaperones to stabilise PAAR domains in specialised effectors
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not simply a passive conduit for T6SS effectors. Recently, specialised
Hcps with C-terminal extension toxins (Hcp-ETs) have been reported
to occur widely in the Enterobacteriaceae (J. Ma et al., 2017).
VgrG-dependent cargo effectors are believed to sit on the outside
of the VgrG–PAAR spike and often have (phospho-)lipase activity, for
example, Tle1 from Enteroaggregative E. coli (EAEC) (Flaugnatti
et al., 2016). Many specialised VgrG proteins with C-terminal toxin
domains have been identified, for example, the actin crosslinking
domain of VgrG-3 from V. cholerae (Pukatzki, Ma, Revel, Sturtevant, &
Mekalanos, 2007). Certain VgrGs also contain C-terminal
“extensions,” which do not confer toxic functions per se, but specifi-
cally bind and recruit other effectors (Bondage, Lin, Ma, Kuo, &
Lai, 2016; Flaugnatti et al., 2016). For example, the EAEC VgrG has a
C-terminal extension comprising a DUF2345 domain, which extends
the spike, and a TTR domain, which makes extensive contacts with
Tle1 (Flaugnatti et al., 2020).
The first PAAR-dependent cargo effector, TseT from
P. aeruginosa, was recently reported (Burkinshaw et al., 2018). In con-
trast, PAAR-containing specialised effectors are widespread, with a
remarkable variety of anti-bacterial functions. They include Rhs pro-
teins, a family of large polymorphic toxin proteins, which frequently
possess C-terminal nuclease domains, and whose effector domains
are predicted to be encased in a shell-like structure (Coulthurst, 2019;
Koskiniemi et al., 2013). Indeed, it has been shown that the C-terminal
domains of even very large specialised VgrG and PAAR proteins may
fit within a variable cavity between the spike components and the
remainder of the T6SS baseplate (Nazarov et al., 2018).
T6SSs typically contain multiple homologues of Hcp, VgrG and/or
PAAR proteins and their genes are often linked with their cognate
effectors, both within the main T6SS gene cluster and dispersed
around the genome. It has been shown that different combinations of
Hcp, VgrG and PAAR proteins can assemble functional T6SSs, particu-
larly specific VgrG–PAAR spike combinations. These different assem-
blies then lead to the delivery of alternative sets of effectors during
individual firing events (Cianfanelli et al., 2016; Wood, Howard,
Wettstadt, et al., 2019).
2.1 | Adaptors and secretion motifs of T6SS
effectors
Some effectors require dedicated adaptor proteins for delivery by the
T6SS. Several families of adaptor proteins necessary for stabilisation
and/or loading of the cognate effectors onto the VgrG–PAAR spike
have been characterised. The DUF4123 domain-containing family
was identified in V. cholerae (TecL/Tap-1), Agrobacterium tumefaciens
(Tap-1) and Aeromonas hydrophila (TecC) (Bondage et al., 2016; Liang
et al., 2015; Unterweger et al., 2015). These adaptor proteins interact
directly with their cognate effectors and the C-terminal extension of
the correct VgrG, allowing VgrG-dependent cargo effectors to be
loaded. A co-adaptor protein may also be needed to stabilise the
adaptor protein, as reported for TecT and co-TecT in P. aeruginosa
(Burkinshaw et al., 2018). Proteins containing DUF2169 domains are
encoded upstream of some PAAR-containing specialised effectors and
may also represent adaptors facilitating loading onto VgrG proteins
(Bondage et al., 2016), while a DUF2875-containing adaptor, Tla3, is
required to load a cargo effector, Tle3, onto a specialised VgrG,
VgrG2b (Berni, Soscia, Djermoun, Ize, & Bleves, 2019). Adaptor pro-
teins containing the DUF1795 domain represent a family of chaper-
one proteins required for the stability of PAAR-containing specialised
effectors. These chaperones include EagR proteins, required for
stabilisation and delivery of Rhs proteins in Serratia marcescens
(Cianfanelli et al., 2016), and EagT6 of P. aeruginosa, which is required
for the stability and loading of the PAAR-containing effector, Tse6,
onto VgrG1 (Whitney et al., 2015). EagT6 binds to the PAAR-
containing domain of Tse6 in the secreting cell and protects trans-
membrane helices that are ultimately used to generate a pore in the
inner membrane of the target cell through which the effector domain
translocates to the cytoplasm (Quentin et al., 2018). None of the
above adaptor proteins are secreted with their cognate effectors and
thus must be lost during the process of T6SS assembly and firing.
Recognition of effectors by the T6SS machinery is built-in for
specialised effectors, but remains incompletely understood for cargo
effectors. No universal secretion signals or motifs seem to exist, even
within effectors using the same type of core component. Two
domains found in certain subsets of T6SS effectors with diverse activ-
ities and which apparently represent effector recognition motifs have
been identified: marker for type sIX effectors (MIX) (Salomon
et al., 2014) and found in type sIX effectors (FIX) (Jana, Fridman,
Bosis, & Salomon, 2019). Both MIX and FIX are usually found at the
N-terminus of proteins also containing toxin/effector domains and
likely represent intrinsic adaptor domains. In general, adaptor proteins
have been suggested to allow a wider range of cargo effectors to
interact with core components and to be co-acquired and co-evolve
with new effectors (Unterweger et al., 2015). Overall, different combi-
nations of core Hcp, VgrG and PAAR components, together with cog-
nate adaptor proteins, allow one T6SS to deliver multiple, structurally
diverse effector proteins.
3 | ANTI-BACTERIAL EFFECTORS
DELIVERED BY THE T6SS
Anti-bacterial effectors represent the majority of identified and
characterised effectors of the T6SS. As shown in Figure 2, T6SSs
deliver a variety of anti-bacterial effector proteins into neighbouring
bacterial cells, which act by different mechanisms to compromise con-
served cellular structures and molecules, leading to lysis or growth
inhibition of targeted cells.
3.1 | Cell wall-disrupting effectors
The cell wall of Gram-negative bacteria, an essential structure needed
for protection and stabilisation of the cell, is located within the peri-
plasm and consists mainly of a thin layer of peptidoglycan (PG). PG
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comprises glycan strands linked by peptide cross-bridges and is a
common target during interbacterial competition (Silhavy, Kahne, &
Walker, 2010). Toxins with PG hydrolase activities represent a large
and well-characterised class of T6SS effectors. T6SS PG amidase
effectors, which cleave the peptide cross-bridges, were initially classi-
fied into four families named Type VI amidase effectors (Tae)1–4
(Russell et al., 2012). These families differ in their cleavage specificity,
with Tae2 and Tae3 hydrolysing peptide cross-bridges between
mDAP and D-Ala, whereas Tae1 and Tae4 cleave between D-Glu and
mDAP. As more PG amidase effectors have been identified and stud-
ied, the diversity within this class has become further apparent. Two
members of the Tae4 family in one strain of S. marcescens, Ssp1 and
Ssp2, have distinct substrate specificities and unrelated immunity pro-
teins (Srikannathasan et al., 2013), while an amidase effector recently
identified in E. coli belongs to a distinct family of PG amidases, named
TaeX, which cleave between N-acetylmuramoyl and L-Ala (J. Ma, Sun,
Pan, Lu, & Yao, 2018). PG glycoside hydrolase effectors, which cleave
the glycan backbone of PG, have been classified in three families, Type
VI secretion glycoside hydrolase effectors (Tge)1–3. Tge1, and likely
Tge3, show β-(1,4)-N-acetylmuramidase activity, while Tge2 is predicted,
on the basis of structural data, to show N-acetylglucosaminidase activity
(Whitney et al., 2013). In addition, specialised VgrG effectors that act
F IGURE 2 Anti-bacterial effectors and cognate immunity proteins. Schematic illustration of the different classes of anti-bacterial effectors
and protection by cognate immunity proteins. When a genetically identical sibling cell is targeted by the T6SS (left), immunity proteins for each
effector are located at the site of action of the effector, where they can intercept the incoming effector, binding it tightly and neutralising its
toxicity. In contrast, when a susceptible competitor bacterium is targeted (right), it does not encode the cognate immunity proteins and the
effectors exert their toxic effects, killing or disabling the target cell. CP, cytoplasm; IM, inner membrane; OM, outer membrane; PG, peptidoglycan
cell wall
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upon the cell wall have been identified, including VgrG-3 of V. cholerae,
which has a PG glycoside hydrolase domain (Brooks, Unterweger,
Bachmann, Kostiuk, & Pukatzki, 2013), and VgrG2b of P. aeruginosa,
which has a C-terminal zinc-metallopeptidase domain that has been
suggested to act on proteins required for PG remodelling (Berni
et al., 2019; Wood, Howard, Förster, et al., 2019).
3.2 | Membrane-disrupting effectors
Many T6SS-delivered effectors disrupt the membranes of bacterial
cells by degrading their lipid constituents. Russell et al. (2013) identi-
fied five families of predicted (phospho-)lipase effectors, named Type
VI lipase effectors (Tle)1–5. They showed that Tle1 and Tle2 have
phospholipase A2 (PLA2) and A1 (PLA1) activities, respectively, while
Tle5 are phospholipase D enzymes. Subsequently, the metagenomic
analysis indicated that such effectors are widespread, with consider-
able diversity in their structure and predicted activity (Egan, Reen, &
O'Gara, 2015), while Tle1 from EAEC was shown to display both PLA1
and PLA2 activities consistent with diversity even within the desig-
nated Tle families (Flaugnatti et al., 2016).
T6SS effectors with membrane pore-forming activity have also
been identified. VasX from V. cholerae was reported to share homology
with pore-forming colicins and its action was shown to cause a loss of
membrane potential and increase in cellular permeability (Miyata,
Unterweger, Rudko, & Pukatzki, 2013). The impact of intoxication by
Tse4 of P. aeruginosa indicates that this effector forms ion-selective
pores in target cells, leading to dissipation of the membrane potential
without causing permeability to larger molecules (LaCourse
et al., 2018). Similarly, a distinct effector, Ssp6 of S. marcescens, causes
inner membrane depolarisation in vivo and forms cation-selective pores
in artificial lipid bilayers in vitro (Mariano et al., 2019). Interestingly,
Ssp6 intoxication may also cause a loss of outer membrane
(OM) integrity, although it is unclear if this is a direct or indirect effect.
3.3 | Nucleic acid-targeting effectors
Toxins with nuclease activities also occur widely as T6SS-delivered
effectors. Many T6SS-associated Rhs proteins (PAAR-containing spe-
cialised effectors), including Rhs1 and Rhs2 from Dickeya dadantii,
have C-terminal endonuclease effector domains, which act to degrade
target cell DNA (Koskiniemi et al., 2013). A. tumefaciens can deliver
two DNase effectors, Tde1 and Tde2 (Type VI DNase effector). Both
contain a toxin_43 nuclease domain, but Tde1 is a VgrG-dependent
cargo effector and Tde2 a specialised PAAR effector (Bondage
et al., 2016). Recently, Jana et al. (2019) identified an effector in V. par-
ahaemolyticus that carries a novel but widely-occurring C-terminal
DNase domain proposed to be part of the PD-(D/E)xK phosphodies-
terase superfamily. More broadly, many other effectors, particularly
PAAR-containing specialised effectors, are predicted to possess
DNase, RNase or deaminase activity according to bioinformatic ana-
lyses (Coulthurst, 2019).
3.4 | Effectors targeting other essential
cytoplasmic molecules
Recently, the repertoire of characterised T6SS toxins has been
expanded by effectors that disrupt other cellular molecules. The spe-
cialised PAAR-containing effector, Tre1 of S. proteamaculans, displays
ADP-ribosyltranferase activity, adding ADP-ribose to FtsZ, a tubulin-like
protein essential for bacterial cell division. ADP-ribosylation blocks poly-
merisation of FtsZ, inhibiting cell division and leading to the death of
intoxicated cells (Ting et al., 2018). The essential cytoplasmic cofactors,
NAD(P)+, are targeted by families of glycohydrolase effectors called
Type VI secretion NADase effectors (Tne)1–2. Tse6 (Tne1) of
P. aeruginosa and Tne2 of P. protegens both hydrolyse NAD+ and NADP+
in intoxicated cells, depleting the cofactor levels and leading to bacterio-
stasis (Tang, Bullen, Ahmad, & Whitney, 2018; Whitney et al., 2015).
The energy balance of intoxicated cells can be disrupted directly by a
new class of T6SS effector, exemplified by Tas1 from P. aeruginosa.
Tas1 very rapidly synthesises (p)ppApp, depleting cellular ATP (and
ADP), leading to irreversible disruption of essential metabolic pathways
and cell death (Ahmad et al., 2019). Tas1 intoxication likely also accentu-
ates the impact of other effectors by disabling ATP-dependent cellular
repair pathways, and its product, (p)ppApp, also inhibits purine biosyn-
thesis, further reducing the likelihood of cellular recovery.
3.5 | Immunity proteins
In order to protect themselves from intoxication by their own effector
proteins, or those injected by neighbouring sibling cells, secreting bac-
terial cells possess immunity proteins specific to each of their anti-
bacterial effector proteins (Figure 2). These immunity proteins are
encoded adjacent to the cognate effector and reside in the cellular
compartment in which the effector acts. Immunity proteins bind
tightly and specifically to the cognate effector to neutralise its action,
typically occluding the active site of enzymatic effectors
(Coulthurst, 2019). In the case of the ADP-ribosyltransferase effector,
Tre1, the immunity protein, Tri1, can also act as an ADP-
ribosylhydrolase. This allows Tri1 to remove ADP-ribose groups intro-
duced by Tre1 and potentially also protect against other ADP-
ribosyltransferase toxins (Ting et al., 2018). Mounting evidence sug-
gests that bacteria may retain or actively accumulate “orphan” immu-
nity proteins, those for effectors they do not (any longer) encode, as a
means of protection against T6SS attacks by other bacteria in their
niche (Ross et al., 2019).
4 | ANTI-EUKARYOTIC EFFECTORS
DELIVERED BY THE T6SS
The T6SS can also deliver effectors that target various cellular pro-
cesses and structures in eukaryotic cells. These effectors may facili-
tate host invasion and pathogenesis, or, alternatively, be deployed to
survive or compete against eukaryotic microbes.
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4.1 | Disruption of the actin cytoskeleton
Many anti-eukaryotic effectors target the actin cytoskeleton of host
cells. For example, VgrG1 of A. hydrophila has actin ADP-ribosylase
activity, which prevents actin polymerisation, and induces caspase
9-mediated apoptosis (Suarez et al., 2010), while VgrG-1 of V. cholerae
has an actin crosslinking domain, which inhibits cytoskeleton
rearrangement and phagocytosis, and promotes inflammatory diar-
rhoea in vivo (A. T. Ma & Mekalanos, 2010). TecA from Burkholderia
cenocepacia can disrupt the actin cytoskeleton of macrophages by
deamidating Rho GTPases, triggering inflammation through activation
of the Pyrin inflammasome (Aubert et al., 2016), while the
V. proteolyticus effector, Vpr01570, contains a CNF1-like deamidase
domain that can induce cytoskeleton rearrangements in macrophages
(Ray et al., 2017).
4.2 | Cell invasion and colonisation
Other effectors can promote internalisation, intramacrophage growth
or phagosomal escape. OpiAB and PdpCD, delivered by the T6SS of
Francisella tularensis, contribute to intramacrophage growth. PdpC is
required for phagosomal escape by the bacterium, and, in the absence
of PdpC, OpiA promotes phagosomal escape through its PI(3)-kinase
activity (Brodmann, Dreier, Broz, & Basler, 2017; Ledvina et al., 2018).
The effector domain of VgrG2b can be delivered into the epithelial
cells by the P. aeruginosa H2-T6SS, where it interacts with the micro-
tubule network (specifically γ-tubulin ring complex) to allow normally
non-phagocytic cells to internalise the bacterium (Sana et al., 2015).
This function is in addition to the anti-bacterial activity of the domain
(Berni et al., 2019; Wood, Howard, Förster, et al., 2019), making it an
example of a “trans-kingdom” effector, acting on both prokaryotic and
eukaryotic cells. Several P. aeruginosa phospholipase effectors also
have trans-kingdom activity. TplE (Tle4 family) localises to the endo-
plasmic reticulum in eukaryotic cells, where it activates the unfolded
protein response, leading to autophagy (Jiang et al., 2016), while PldA
and PldB (Tle5 family) promote invasion of eukaryotic cells through
the activation of the PI3K/Akt signalling pathway (Jiang, Waterfield,
Yang, Yang, & Jin, 2014). EvpP from Edwardsiella tarda can also pro-
mote host-cell invasion, this time by inhibiting activation of the
NLRP3 inflammasome, ultimately promoting bacterial colonisation
in vivo (Chen et al., 2017). Finally, VgrG5 of B. pseudomallei is required
for host cell fusion and cell-to-cell spread of bacteria, with its
C-terminal domain proposed to insert into host cell membranes to
mediate the fusion event (Toesca, French, & Miller, 2014).
4.3 | Anti-amoebal and anti-fungal effectors
Three T6SS effectors contribute to protecting V. cholerae against Dic-
tyostelium discoideum predation: VgrG-1 (actin crosslinking), TseL
(lipase) and VasX (membrane-disrupting); with TseL and VasX being
trans-kingdom effectors (Dong, Ho, Yoder-Himes, & Mekalanos, 2013).
The T6SS has been shown to mediate resistance to amoebal predation
in other organisms, for example, Xanthomonas citri (Bayer-Santos
et al., 2018), but the effectors responsible are yet to be identified. The
first two T6SS effectors specifically targeting fungal cells were recently
identified in S. marcescens. Tfe1 intoxication causes plasma membrane
depolarisation and can ultimately lead to fungal cell death, while Tfe2
causes disruption to nutrient transport and metabolism and induces
autophagy, most likely as a starvation response (Trunk et al., 2018).
Anti-fungal T6SS effectors are likely to be widespread, broadening the
potential influence of the T6SS on many polymicrobial communities,
which often contain fungal and bacterial cells.
5 | T6SS EFFECTORS INVOLVED IN METAL
UPTAKE
Recent studies have revealed that some effectors secreted by the
T6SS do not need to be delivered into rival cells to perform their bio-
logical function, but instead play a role in metal uptake when secreted
into the extracellular environment. During oxidative stress, the
B. thailandensis T6SS-4 secretes TseM, which binds extracellular Mn2+
ions and subsequently interacts with a TonB-dependent OM trans-
porter, MnoT, to allow active transport of manganese into the cell (Si,
Zhao, et al., 2017). The same T6SS also secretes TseZ, a metallophore
used for scavenging zinc and related to the first identified metal
uptake effector, YezP of Yersinia pseudotuberculosis. During severe
oxidative stress, the HmuR OM transporter switches from
transporting heme to zinc, allowing Zn2+ bound by TseZ to be impo-
rted (Si, Wang, et al., 2017). In P. aeruginosa, the T6SS-secreted effec-
tor, TseF, participates in Fe3+ uptake in a distinct manner.
Extracellular TseF interacts with Fe3+−bound PQS (a quinolone signal-
ling molecule) present in OM vesicles. TseF then docks with the OM
receptor, FptA, and porin OprF to facilitate transport of Fe3+ from the
OM vesicles into the bacterium (Lin et al., 2017). In the same organ-
ism, the Azu effector is reported to scavenge Cu2+ and deliver it to
the OM transporter, OprC (Han et al., 2019). T6SS-dependent secre-
tion of metal uptake effectors may allow the secreting bacteria to effi-
ciently scavenge scarce metal ions from the extracellular environment
and thus outcompete bacterial competitors, and, in addition, make
them better able to survive within host niches, which are typically
metal-limited. Indeed, it appears that TseZ, TseM and TseF are able to
confer such competitive advantages (Lin et al., 2017; Si, Wang,
et al., 2017; Si, Zhao, et al., 2017).
6 | PERSPECTIVES AND FUTURE
DIRECTIONS
The T6SS is a highly versatile weapon for bacterial competitiveness,
with mounting evidence that T6SSs play key roles in shaping the com-
position and dynamics of diverse microbial communities, including
microbiota, reviewed by Coulthurst (2019) and Allsopp, Bernal, Nolan,
and Filloux (2020). T6SS-mediated competition may also represent a
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key driver for bacterial evolution, with ongoing acquisition and diver-
sification of new effector and immunity genes resulting in inter-
species and inter-strain “arms races.” In addition, the action of many
T6SS anti-bacterial effectors, such as cell wall hydrolases, can lead to
lysis of targeted cells, providing the opportunity for naturally
competent-attacking bacteria to acquire new genes, including antibi-
otic resistance determinants and new effector–immunity pairs
(Coulthurst, 2019; Matthey et al., 2019). Thus, T6SS-dependent hori-
zontal gene transfer provides an indirect competitive fitness advan-
tage to go alongside the immediate and direct fitness advantage of
killing or disabling rival bacterial cells in the same niche. Clearly, the
large and diverse repertoire of anti-bacterial effectors, which can be
deployed by the T6SS, is central to its effectiveness as a weapon for
inter-bacterial competition. Effectors acting against eukaryotic
microbes, while currently far less explored, should similarly promote
bacterial survival in microbial communities, while those involved in
metal scavenging represent another way to gain an edge in the fierce
competition between microbes. The fact that T6SSs can also deploy
anti-host effectors, and the existence of “trans-kingdom” effectors,
highlights the impressive versatility of this system.
Looking forward, the mode of action of many anti-bacterial effec-
tors remains unknown, and, given the diversity identified so far and
evident from genomic surveys, we anticipate many more effectors
remain to be discovered. Similarly, it is likely that we have only
scratched the surface in terms of identifying anti-eukaryotic and
contact-independent effectors. We also lack a full understanding of
the mechanisms by which effectors are recognised and recruited by
the T6SS. This includes how the need for specific recognition of effec-
tors by the T6SS machinery may limit the horizontal acquisition of
new effectors, and how strategies, such as modular adaptor proteins,
may help to overcome this barrier. Importantly, evidence for synergis-
tic action between different effectors has been reported (LaCourse
et al., 2018). Defining such synergies will be critical for understanding
the overall impact of the T6SS on targeted cells. Finally, further work
is required to understand how and where effectors are released from
T6SS components in target cells and how target cell functions may
promote or protect against effector toxicity. Ultimately, deciphering
the mechanisms and roles of T6SS effectors will allow us to under-
stand how T6SSs influence microbial communities and provide new
leads in the development of anti-microbial strategies, hopefully by all-
owing us to “learn from the experts” how microbes can so effectively
kill each other.
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